US Appeals Court Denies Genentech Injunction Over Amgen's 'At Risk' Trastuzumab Launch

 
• By David Wallace
Risk_Scales
After Weighing Genentech’s Arguments, The Court Decided Against An Injunction • Source: Shutterstock

More from Biosimilars

More from Products